Pearls of Botox usage

Techniques in Ophthalmology

Volumn 4, Issue 4, 2006, Pages 165-169

  Taban, Mehryar ^a   Perry, Julian D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; BOTULINUM TOXIN B; CBTXA; EXOTOXIN; RELOXIN; UNCLASSIFIED DRUG;

APRAXIA; AQUEOUS TEAR DEFICIENCY; BLEPHAROSPASM; CLOSTRIDIUM BOTULINUM; DRUG APPROVAL; DRUG CONTRAINDICATION; DRUG COST; DRUG DOSAGE FORM; DRUG DOSAGE FORM COMPARISON; DRUG EFFECT; DRUG FORMULATION; DRUG INJECTION VOLUME; DRUG LABELING; DRUG MARKETING; DRUG MECHANISM; DRUG MIXTURE; DRUG STORAGE; DRUG SYNTHESIS; DRUG USE; DYSTONIA; ENDOCRINE OPHTHALMOPATHY; ENTROPION; ESTHETIC SURGERY; EYE DISEASE; FACE DISORDER; FACIAL NERVE DISEASE; FREEZING; HEMIFACIAL SPASM; HUMAN; HYPERHIDROSIS; HYPERSECRETION DISORDER; INJECTION PAIN; INJECTION SITE PAIN; INTRAOCULAR HYPERTENSION; KERATOPATHY; LAGOPHTHALMOS; MECHANICAL STRESS; MUSCLE CRAMP; MYOCLONUS; MYOKYMIA; NYSTAGMUS; OFF LABEL DRUG USE; OPTIC NERVE DISEASE; PLASTIC SURGERY; PREFORMULATION; PRIORITY JOURNAL; REVIEW; SHELF LIFE; STRABISMUS; TENSION HEADACHE; TRANSFORMED MIGRAINE; TREMOR; WRINKLE;

EID: 33845979869     PISSN: 15421929     EISSN: 15421937     Source Type: Journal    
DOI: 10.1097/01.ito.0000249743.76458.05     Document Type: Review

References (27)

1. Scott AB. Development of botulinum toxin therapy. Dermatol Clin. 2004;22:131-133.
2. Scott AB, Rosenbaum A, Collins CC. Pharmacologic weakening of extraocular muscles. Invest Ophthalmol. 1973;12:924-927.
3. Kaltreider SA, Kennedy RH, Woog JJ, et al. American Academy of Ophthalmology; Ophthalmic Technology Assessment Committee Oculoplastics Panel. Cosmetic oculofacial applications of botulinum toxin: a report by the American Academy of Ophthalmology. Ophthalmology. 2005;112:1159-1167.
4. Foster JA, Wulc AE, Holck DE. Cosmetic indications for botulinum A toxin. Semin Ophthalmol. 1998;13:142-148.
5. Osako M, Keltner JL. Botulinum A toxin (Oculinum) in ophthalmology. Surv Ophthalmol. 1991;36:28-46.
6. Klein AW. Dilution and storage of botulinum toxin. Dermatol Surg. 1998;24:1179-1180.
7. Alam M, Dover JS, Arndt KA. Pain associated with injection of botulinum A exotoxin reconstituted using isotonic sodium chloride with and without preservative: a double-blind, randomized controlled trial. Arch Dermatol. 2002;138:510-514.
8. Hexsel DM, De Almeida AT, Rutowitsch M, et al. Multicenter, double-blind study of the efficacy of injections with botulinum toxin type A reconstituted up to six consecutive weeks before application. Dermatol Surg. 2003;29:523-529.
9. Alam M, Yoo SS, Wrone DA, et al. Sterility assessment of multiple use botulinum A exotoxin vials: a prospective simulation. J Am Acad Dermatol. 2006;55:272-275.
10. Mannor GE. Practical aspects of cosmetic botulinum toxin. Int Ophthalmol Clin. 2005;45:99-106.
11. Jankovic J, Vuong KD, Ahsan J. Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia. Neurology. 2003;60:1186-1188.
12. Klein AW. Contraindications and complications with the use of botulinum toxin. Clin Dermatol. 2004;22:66-75.
13. Wollina U, Konrad H. Managing adverse events associated with botulinum toxin type A: a focus on cosmetic procedures. Am J Clin Dermatol. 2005;6:141-150.
14. Patrinely JR, Whiting AS, Anderson RL. Local side effects of botulinum toxin injections. Adv Neurol. 1988;49:493-500.
15. Charles PD. Botulinum neurotoxin serotype A: a clinical update on non-cosmetic uses. Am J Health Syst Pharm. 2004;61:S11-S23.
16. Barnhill BJ, Holbert MD, Jackson NM, et al. Using pressure to decrease the pain of intramuscular injections. J Pain Symptom Manage. 1996;12:52-58.
17. Carruthers JD. Ophthalmologic use of botulinum A exotoxin. Can J Ophthalmol. 1985;20:135-141.
18. Clarke JR, Spalton DJ. Treatment of senile Entropion with botulinum toxin. Br J Ophthalmol. 1988;72:361-362.
19. Sahlin S, Chen E, Kaugesaar T, et al. Effect of eyelid botulinum toxin injection on lacrimal drainage. Am J Ophthalmol. 2000;129:481-486.
20. Morgenstern KE, Evanchan J, Foster JA, et al. Botulinum toxin type a for dysthyroid upper eyelid retraction. Ophthal Plast Reconstr Surg. 2004;20:181-185.
21. Hoffman RJ. Treatment of Frey's syndrome (gustatory sweating) and 'crocodile tears' (gustatory epiphora) with purified botulinum toxin. Ophthal Plast Reconstr Surg. 2000;16:289-291.
22. Frankel AS, Kamer FM. Chemical browlift. Arch Otolaryngol Head Neck Surg. 1998;124:321-323.
23. Muhlbauer W, Holm C. Eyebrow asymmetry: ways of correction. Aesthetic Plast Surg. 1998;22:366-371.
24. Ellis DA, Ran AK. Cosmetic upper-facial rejuvenation with botulinum. J Otolaryngol. 1997;26:92-96.
25. Carruthers J, Carruthers A. Aesthetic botulinum A toxin in the mid and lower face and neck. Dermatol Surg. 2003;29:468-476.
26. Blitzer A, Binder WJ. Cosmetic uses of botulinum neurotoxin type A: an overview. Arch Facial Plast Surg. 2002;4:214-220.
27. Matarasso SL. Comparison of botulinum toxin types A and B: a bilateral and double-blind randomized evaluation in the treatment of canthal rhytides. Dermatol Surg. 2003;29:7-13.